Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a sodium-independent transporter which mediates cellular uptake of organic ions in the liver. Its substrates include bile acids, bromosulphophthalein, and some steroidal compounds. The protein is a member of the SLC21A family of solute carriers. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2008]
SLCO1A2 (Solute Carrier Organic Anion Transporter Family Member 1A2) is a Protein Coding gene. Diseases associated with SLCO1A2 include Intrahepatic Cholestasis Of Pregnancy and Cholelithiasis. Among its related pathways are Transport of vitamins, nucleosides, and related molecules and Synthesis of bile acids and bile salts. Gene Ontology (GO) annotations related to this gene include transporter activity and organic anion transmembrane transporter activity. An important paralog of this gene is SLCO1C1.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH12J021323 | Promoter/Enhancer | 1 | EPDnew Ensembl ENCODE dbSUPER | 600.2 | +95.0 | 94970 | 2 | NANOG POU5F1 | SLCO1A2 IAPP piR-39858-114 lnc-SLCO1A2-1 SLCO1B1 | |
GH12J021419 | Promoter | 0.9 | Ensembl | 600.7 | +0.1 | 93 | 0.6 | LEF1 IKZF1 PKNOX1 BRD9 ZNF24 SOX6 MGA ZNF184 POLR2A MTA3 | SLCO1A2 lnc-SLCO1A2-1 piR-46002-112 piR-57176-115 piR-45012-104 PYROXD1 IAPP | |
GH12J021275 | Enhancer | 0.2 | FANTOM5 | 4.6 | +143.5 | 143546 | 0.1 | piR-51855-007 piR-60926 GYS2 SLCO1B1 SLCO1A2 SLCO1B3 KCNJ8 piR-40110-126 IAPP lnc-SLCO1A2-1 | ||
GH12J021416 | Enhancer | 0.5 | Ensembl ENCODE | 0.7 | +3.2 | 3193 | 1.2 | SP1 NR3C1 | SLCO1A2 lnc-SLCO1A2-1 piR-45012-104 piR-41525-125 IAPP | |
GH12J021413 | Enhancer | 0.8 | Ensembl | 0.4 | +5.7 | 5693 | 0.2 | LEF1 JUND PKNOX1 DPF2 HDAC1 SOX6 TCF12 EP300 NFE2 HDAC2 | SLCO1A2 piR-45012-104 lnc-SLCO1A2-1 piR-41525-125 IAPP |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005515 | protein binding | IEA | -- |
GO:0008514 | organic anion transmembrane transporter activity | TAS | 9007731 |
GO:0015125 | bile acid transmembrane transporter activity | TAS | -- |
GO:0015347 | sodium-independent organic anion transmembrane transporter activity | IBA | 21873635 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005886 | plasma membrane | IEA,TAS | -- |
GO:0005887 | integral component of plasma membrane | IBA | 21873635 |
GO:0016020 | membrane | IEA | -- |
GO:0016021 | integral component of membrane | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006811 | ion transport | IEA | -- |
GO:0015711 | organic anion transport | TAS | 9007731 |
GO:0015721 | bile acid and bile salt transport | TAS | -- |
GO:0043252 | sodium-independent organic anion transport | TAS | -- |
GO:0055085 | transmembrane transport | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Rifampicin | Approved | Pharma | Agonist, Inhibitor, Inhibition, Transporter, inhibitor, binder | Pregnane X receptor agonist; antibiotic | 456 | |
Rocuronium | Approved | Pharma | Transporter, substrate | TGF-βR I kinase inhibitor | 431 | |
Probenecid | Approved, Investigational | Pharma | Inhibitor, Inhibition, Activator, Transporter, inhibitor | 40 | ||
Bumetanide | Approved | Pharma | Agonist, Inhibitor, Inhibition, Transporter, substrate | NKCC cotransporter inhibitor, Na+/2Cl-/K+ (NKCC) symporter inhibitor | 26 | |
cholic acid | Approved | Pharma | Agonist, Full agonist, Transporter, substrate, inhibitor, inducer | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid |
|
58814-71-4 |
|
|||
1,3,12-Trihydroxycholan-24-oic acid |
|
63266-91-1 |
|
|||
1,3,7,12-Tetrahydroxycholan-24-oic acid |
|
63266-89-7 |
|
|||
12a-Hydroxy-3-oxocholadienic acid |
|
13535-96-1 |
|
|||
12b-Hydroxy-5b-cholanoic acid |
|
15173-23-6 |
|
ExUns: | 1a | · | 1b | · | 1c | ^ | 2 | ^ | 3a | · | 3b | · | 3c | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14 | ^ | 15 | ^ | 16a | · | 16b | ^ | 17 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | |||||||||||||||||||||||||||||||||||||||||
SP2: | |||||||||||||||||||||||||||||||||||||||||||
SP3: | - | ||||||||||||||||||||||||||||||||||||||||||
SP4: | - |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | SLCO1A2 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | SLCO1A2 30 |
|
||
OATPA 31 |
|
OneToOne | |||
Cow (Bos Taurus) |
Mammalia | SLCO1A2 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Slco1a5 30 17 31 |
|
OneToMany | |
Slco1a4 31 |
|
OneToMany | |||
Slco1a1 31 |
|
OneToMany | |||
Gm6614 31 |
|
OneToMany | |||
Slco1a6 31 |
|
OneToMany | |||
Gm5724 31 |
|
OneToMany | |||
Rat (Rattus norvegicus) |
Mammalia | Slco1a5 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | SLCO1A2 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | SLCO1A2 30 |
|
||
-- 31 |
|
OneToMany | |||
Lizard (Anolis carolinensis) |
Reptilia | -- 31 |
|
OneToMany | |
African clawed frog (Xenopus laevis) |
Amphibia | MGC68666 30 |
|
SNP ID | Clinical significance and condition | Chr 12 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
786223 | Benign: not provided | 21,306,942(-) | T/A | MISSENSE_VARIANT | |
788577 | Benign: not provided | 21,300,490(-) | G/A | SYNONYMOUS_VARIANT | |
VAR_036409 | A colorectal cancer sample | p.Val220Ile | |||
rs10841795 | - | p.Ile13Thr | |||
rs11568557 | - | p.Thr668Ser |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv1404n100 | CNV | loss | 25217958 |
esv1146701 | CNV | insertion | 17803354 |
esv2750499 | CNV | gain | 17666407 |
esv3628799 | CNV | loss | 21293372 |
esv3628806 | CNV | loss | 21293372 |
nsv1040888 | CNV | loss | 25217958 |
nsv1115426 | CNV | duplication | 24896259 |
nsv469161 | CNV | loss | 19166990 |
nsv469162 | CNV | loss | 19166990 |
nsv470274 | CNV | loss | 18288195 |
nsv475260 | CNV | novel sequence insertion | 20440878 |
nsv515735 | CNV | gain+loss | 19592680 |
nsv519603 | CNV | gain+loss | 19592680 |
nsv557734 | CNV | loss | 21841781 |
nsv557735 | CNV | loss | 21841781 |
nsv557736 | CNV | loss | 21841781 |
nsv557737 | CNV | loss | 21841781 |
nsv557738 | CNV | loss | 21841781 |
nsv557739 | CNV | loss | 21841781 |
nsv557740 | CNV | loss | 21841781 |
Disorder | Aliases | PubMed IDs |
---|---|---|
intrahepatic cholestasis of pregnancy |
|
|
cholelithiasis |
|
|
aneurysmal bone cysts |
|
|
cholestasis |
|
|
dubin-johnson syndrome |
|
|